trk inhibition’s future role in precision medicine
Published 5 years ago • 56 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
1:16
the future of trk inhibitors in lung cancer treatment
-
4:43
trk inhibition: overcoming acquired resistances
-
4:36
trk inhibition: personal experience with larotrectinib
-
2:18
further trk inhibitor development
-
4:40
use of trk inhibition in specific tumor types
-
6:48
trk inhibition’s potential role in clinical practice
-
5:16
an overview of the trk inhibition landscape
-
4:07
trk inhibition: ongoing challenges
-
19:03
the era of precision oncology | dr. jaime l. schneider
-
56:14
improving outcomes in resectable nsclc with egfr-targeted therapy
-
27:06
dr. hong's biotechnology lecture 04: cancers and antibody drug conjugate
-
3:30
favorable safety profile in novel trk inhibitor
-
5:11
using next-gen sequencing to select for trk inhibitors
-
3:54
managing patients on trk inhibitors
-
4:52
trk as ideal candidate for targeted therapy
-
56:06
challenging cases in precision medicine and immuno-oncology (ntrk )
-
4:09
moving forward with trk inhibition
-
7:31
precision medicine in oncology: overcoming obstacles
-
6:02
early development of trk inhibitor–larotrectinib
-
1:12
highlighting promising trk inhibitors for the treatment of thyroid cancer
-
23:03
ntrk gene fusion as novel target for cancer therapy and trk inhibitors
-
0:54
efficacy results for loxo-101 in trk fusion cancers